Laura Brege

Laura Brege has served as a director of Acadia since May 2008.

Ms. Brege is Managing Director of Cervantes Life Science Partners, LLC., a healthcare advisory and consulting company. Prior to joining Cervantes Life Science Partners from September 2012 to July 2015, Ms. Brege served as Chief Executive Officer and President of Nodality, Inc., a privately held biotechnology company focused on oncology and immunology.

Previously, Ms. Brege held several senior-level positions at Onyx Pharmaceuticals, Inc. from June 2006 to December 2011, including Executive Vice President and Chief Operating Officer. Before joining Onyx, Ms. Brege was a general partner at Red Rock Capital Management, a venture capital firm specializing in early stage financing for technology companies. Prior to Red Rock, she was Senior Vice President and Chief Financial Officer at COR Therapeutics. Earlier in her career, Ms. Brege served as Vice President and Chief Financial Officer at Flextronics and Vice President and Treasurer of The Cooper Companies.

Ms. Brege serves on the boards of Dynavax Technologies Corporation, HLS Therapeutics Inc., Pacira BioSciences, Inc., and Portola Pharmaceuticals, Inc. Ms. Brege earned her undergraduate degree from Ohio University and has an M.B.A. from the University of Chicago.